Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-22T15:15:33.108Z Has data issue: false hasContentIssue false
  • English
  • Français

Modification of enteral diets in inflammatory bowel disease

Published online by Cambridge University Press:  28 February 2007

Marian C. Aldhous ,
Doris Meister  and
Subrata Meister
Marian C. Aldhous*
Affiliation:
Gastro-intestinal Laboratory, Western General Hospital, Edinburgh EH4 2XU, UK
Doris Meister
Affiliation:
Gastro-intestinal Laboratory, Western General Hospital, Edinburgh EH4 2XU, UK
Subrata Meister
Affiliation:
Gastro-intestinal Laboratory, Western General Hospital, Edinburgh EH4 2XU, UK
*
*Corresponding Author: Dr Marian C. Aldhous, fax +44 131 537 1007, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The provision of food is thought to promote the maintenance of gut integrity. Nutrients are able to elicit and affect both systemic and mucosal immune responses. Enteral diet therapy has long been known to be efficacious in inflammatory bowel disease (IBD), particularly in childhood Crohn's disease. However, the mechanisms of action of these diets are not clear. Nutritional repletion, direct effects on the gut mucosa or decreased intestinal permeability have all been postulated as being important in nutritional therapy. There is some evidence that the enteral diet has a direct effect on the gut mucosa by reducing cytokine production and the accompanying inflammation, thus leading to decreased intestinal permeability. Modifications of enteral diet composition have been evaluated in many studies. Such modifications include fat and/or protein content and the addition of bioactive peptides. The fatty acid composition of the enteral diet seems to have a much greater impact on its efficacy than modification of the N source. As specific fatty acids are precursors of inflammatory mediators derived from arachidonic acid, the reduction in these components may be beneficial in nutritional therapy for IBD. Addition of bioactive peptides to enteral diet formulas may also have a role; such peptides may have specific growth factor or anti-inflammatory actions. There is still much work to be done to define disease-specific enteral diet formulas that are effective as therapies for both Crohn's disease and ulcerative colitis.

Keywords

Enteral diet formulasCrohn’s diseaseNutritional therapyInflammation
Type
Symposium on ‘Dietary influences on mucosal immunity’
Information
Proceedings of the Nutrition Society , Volume 60 , Issue 4 , November 2001 , pp. 457 - 461
Copyright
Copyright © The Nutrition Society 2001

References

Aslan, A & Triadafilopoulos, G (1992) Fish oil fatty acid supplementation in ulcerative colitis: a double-blind, placebo-controlled, crossover study. American Journal of Gastroenterology 87, 432–437.Google ScholarPubMed
Beluzzi, A, Boschi, S, Brignola, C, Munarini, A, Cariani, G & Miglio, F (2000) Polyunsaturated fatty acids and inflammatory bowel disease. American Journal of Clinical Nutrition 71, Suppl. 1, 339S–342S.CrossRefGoogle Scholar
Beluzzi, A, Brignola, C, Campieri, M, Pera, A, Boschi, S & Miglioli, M (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. New England Journal of Medicine 334, 1557–1560.CrossRefGoogle Scholar
Calder, PC (1998) Dietary fatty acids and the immune system. Nutrition Reviews 56, S70–S83.CrossRefGoogle ScholarPubMed
Casini-Raggi, V, Kam, L, Chong, YJT, Fiocchi, C, Pizarro, TT & Cominelli, F (1995) Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. Journal of Immunology 154, 2434–2440.CrossRefGoogle ScholarPubMed
Croft, NM, Kelly, EJ, Bannerjee, K, Dryhurst, K & Sanderson, I (2001) Diets can modulate the inflammatory response in vivo and in vitro. Gut 48, Suppl. 1, A2.Google Scholar
Cross, ML & Gill, HS (1999) Modulation of immune function by a modified bovine whey protein concentrate. Immnunology and Cell Biology 77, 345–350.CrossRefGoogle ScholarPubMed
de Pablo, M & de Cienfuegos, GA (2000) Modulatory effects of dietary lipids on immune system functions. Immunology and Cell Biology 78, 31–39.CrossRefGoogle ScholarPubMed
Dionne, S, D'Agata, ID, Hiscott, J, Vanounou, T & Seidman, EG (1998) Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease. Clinical and Experimental Immunology 112, 435–442.CrossRefGoogle ScholarPubMed
Donnell, SC, Taylor, N, Van Saene, HKF, Pierro, A & Lloyd, DA (1998) Nutritional implications of gut overgrowth and selective decontamination of the digestive tract. Proceedings of the Nutrition Society 57, 381–387.CrossRefGoogle ScholarPubMed
Donnet-Hughes, A, Duc, N, Serrant, P, Vidal, K & Schiffrin, EJ (2000) Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-β. Immunology and Cell Biology 78, 74–79.CrossRefGoogle ScholarPubMed
Endres, S, Ghorbani, R, Kelley, VE, Georgilis, K, Lonnemann, G, van der Meer, JWM, Cannon, JG, Rogers, TS, Klempner, MS, Weber, PC, Schaefer, EJ, Wolff, SM & Dinarello, CA (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New England Journal of Medicine 320, 265–271.CrossRefGoogle ScholarPubMed
Evers, BM, Izukuru, M, Townsend, CM Jr, Uchida, T & Thompson, JC (1990) Differential effects of gut hormones on pancreas and intestinal growth during administration of an elemental diet. Annals of Surgery 211, 630–638.Google ScholarPubMed
Fell, JME, Paintin, M, Arnaud-Battandier, F, Beattie, RM, Hollis, A, Kitching, P, Donnet-Hughes, A, MacDonald, TT & Walker-Smith, JA (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics 14, 281–289.CrossRefGoogle Scholar
Ferguson, A (1994) Immunological functions of the gut in relation to nutritional state and mode of delivery of nutrients. Gut 35, Suppl. 1, S10–S12.CrossRefGoogle ScholarPubMed
Ferguson, A, Glen, M & Ghosh, S (1998) Crohn's disease: nutrition and nutritional therapy. Ballière's Clinical Gastroenterology 12, 93–114.CrossRefGoogle ScholarPubMed
Geerling, BJ, Van Houwelingen, AC, Badart-Smook, A, Stockbrügger, RW & Brummer, R-JM (1999) Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease compared with controls. American Journal of Gastroenterology 94, 410–417.CrossRefGoogle ScholarPubMed
Gorard, DA, Hunt, JB, Payne-James, JJ, Palmer, KR, Rees, RGP, Clark, ML, Farthing, MJG, Misiewicz, JJ & Silk, DBA (1993) Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 34, 1198–1202.CrossRefGoogle ScholarPubMed
Griffiths, AM, Ohlsson, A, Sherman, PM & Sutherland, LR (1995) Meta-analysis of enteral nutrition as a primary treatment of active Crohn's Disease. Gastroenterology 108, 1056–1067.CrossRefGoogle ScholarPubMed
Hawthorne, AB, Daneshmend, TK, Hawkey, CJ, Belluzi, A, Everitt, SJ, Holmes, GKT, Malkinson, C, Shahhen, MZ & Willars, JE (1992) Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33, 922–928.CrossRefGoogle ScholarPubMed
Hughes, DA & Pinder, AC (2000) n-3 polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes. American Journal of Clinical Nutrition 71, Suppl. 1, 357S–360S.CrossRefGoogle ScholarPubMed
James, MJ, Gibson, RA & Cleland, LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. American Journal of Clinical Nutrition 71, Suppl. 1, 343S–348S.CrossRefGoogle ScholarPubMed
Lamont, AG, Gordon, M & Ferguson, A (1987 a) Oral tolerance in protein-deprived mice. I. Profound antibody tolerance but impaired DTH tolerance after antigen feeding. Immunology 61, 333–337.Google ScholarPubMed
Lamont, AG, Gordon, M & Ferguson, A (1987 b) Oral tolerance in protein-deprived mice. II. Evidence of normal ‘gut processing’ of ovalbumin, but suppressor cell deficiency in deprived mice. Immunology 61, 339–343.Google ScholarPubMed
Lamont, AG, Gordon, M & Ferguson, A (1988) T lymphocyte function in protein deprived mice. Clinical and Experimental Immunology 72, 113–117.Google ScholarPubMed
Leiper, K, Woolner, J, Mullan, MMC, Parker, T, van der Vleit, M, Fear, S, Rhodes, JM & Hunter, JO (2001) A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut 48, Suppl. 1, A2.Google Scholar
Lorenz, R, Weber, PC, Szimnau, P, Heldwien, W, Strasser, T & Loeschke, K (1989) Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease – a randomised, placebo-controlled, double-blind, cross-over trial. Journal of Internal Medicine 225, Suppl. 1, 225–232.CrossRefGoogle Scholar
Lorenz-Meyer, H, Bauer, P, Nicolay, C, Schulz, B, Purrmann, J, Fleig, WE, Scheuren, C, Koop, I, Pudel, V, Carr, L & German Crohn's Disease Study Group (1996) Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. Scandinavian Journal of Gastroenterology 31, 778–785.CrossRefGoogle ScholarPubMed
Mansfield, JC, Giaffer, MH & Holdsworth, CD (1995) Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut 36, 60–66.CrossRefGoogle ScholarPubMed
Meister, D, Aldhous, MC, Bode, J, Shand, A, Johnson, W, Giffen, S & Ghosh, S (2001 a) Anti-inflammatory effect of elemental diet in vitro depends on fatty acid composition. Gut 48, Suppl. 1, A2.Google Scholar
Meister, D, Aldhous, MC, Bode, J, Shand, A, Johnson, W, Giffen, S & Ghosh, S (2001 b) Fish oil substituted elemental diet in ulcerative colitis. Gut 48, Suppl. 1, A73.Google Scholar
Minard, G & Kudsk, KA (1998) Nutritional support and infection: does the route matter? World Journal of Surgery 22, 213–219.CrossRefGoogle ScholarPubMed
Mingrone, G, Greco, AV, Benedetti, G, Capristo, E, Semeraro, R, Zoli, G & Gasbarrini, G (1996) Increased lipid oxidation in Crohn's disease. Digestive Disease and Sciences 41, 72–76.CrossRefGoogle ScholarPubMed
Nieto, N, Fernandez, MI, Torres, MI, Ríos, A, Suarez, MD & Gil, A (1998) Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defence system in rats with experimental ulcerative colitis induced by trinitrobenzene sulphonic acid. Digestive Disease and Sciences 43, 2676–2687.CrossRefGoogle Scholar
Pereira, SP, Cassel, TB, Engelman, JL, Sladen, GE, Murphy, GM & Dowling, RH (1996) Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment. Clinical Science 91, 509–512.CrossRefGoogle ScholarPubMed
Playford, RJ, Macdonald, CE & Johnson, WS (2000) Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. American Journal of Clinical Nutrition 72, 5–14.CrossRefGoogle ScholarPubMed
Rowlands, BJ & Gardiner, KR (1998) Nutritional modulation of gut inflammation. Proceedings of the Nutrition Society 57, 395–401.CrossRefGoogle ScholarPubMed
Royall, D, Jeejeebhoy, KN, Baker, JP, Allard, JP, Habal, FM, Cunnane, SC & Greenberg, GR (1994) Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut 35, 783–787.CrossRefGoogle ScholarPubMed
Serizawa, H, Miura, S, Tashiro, H, Imaeda, H, Shiozaki, H, Ohkubo, N, Kimura, H, Tanaka, S & Tsuchiya, M (1994) Alteration of mucosal immunity after long-term ingestion of an elemental diet in rats. Journal of Parenteral and Enteral Nutrition 18, 141–147.CrossRefGoogle ScholarPubMed
Shand, AG, Meister, D, Aldhous, M, Anderson, N & Ghosh, S (2000) Direct anti-inflammatory effect of elemental diet on Crohn's tissue in vitro. Gut 46, Suppl. 11, W42.Google Scholar
Shoda, R, Matsueda, K, Yamato, S & Umeda, N (1996) Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. American Journal of Clinical Nutrition 63, 741–745.CrossRefGoogle Scholar
Sinha, A, Nightingale, JMD, West, KP, Berlanga-Acosta, J & Playford, RJ (2001) Can left-sided ulcerative colitis be treated with epidermal growth factor enemas? Gut 48, Suppl. 1, A1.Google Scholar
Stenson, WF, Cort, D, Rodgers, J, Burakoff, R, DeSchryver-Keeskemeti, K, Gramlich, TL & Beeken, W (1992) Dietary supplementation with fish oil in ulcerative colitis. Annals of Internal Medicine 116, 609–614.CrossRefGoogle ScholarPubMed
Teahon, K, Pearson, M, Smith, T & Bjarnason, I (1995) Alterations in nutritional status and disease activity during treatment of Crohn's disease with elemental diet. Scandinavian Journal of Gastroenterology 30, 54–60.CrossRefGoogle ScholarPubMed
Teahon, K, Smethurst, P, Pearson, M, Levi, AJ & Bjarnason, I (1991) The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology 101, 84–89.CrossRefGoogle ScholarPubMed
Verma, S, Brown, S, Kirkwood, B & Giaffer, MH (2000) Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomised double-blind trial. American Journal of Gastroenterology 95, 735–739.CrossRefGoogle Scholar
Wallace, FA, Neely, SJ, Miles, EA & Calder, PC (2000) Dietary fats affect macrophage-mediated cytotoxicity towards tumour cells. Immunology and Cell Biology 78, 40–48.CrossRefGoogle ScholarPubMed
Wilschanski, M, Sherman, P, Pencharz, P, Davis, L, Corey, M & Griffiths, A (1996) Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38, 543–548.CrossRefGoogle ScholarPubMed
Wong, CW, Seow, HF, Liu, AH, Husband, AJ, Smithers, GW & Watson, DL (1996) Modulation of immune responses by bovine beta-casein. Immunology and Cell Biology 74, 323–329.CrossRefGoogle ScholarPubMed
Xu, D, Lu, Q & Deitch, EA (1998) Elemental diet-induced bacterial translocation associated with systemic and intestinal immune suppression. Journal of Parenteral and Enteral Nutrition 22, 37–41.CrossRefGoogle ScholarPubMed
Yuceyar, H, Ozutemiz, O, Huseyinov, A, Saruc, M, Alkanat, M, Bor, S, Coker, I & Batur, Y (1999) Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats? Prostaglandins, Leukotrienes and Essential Fatty Acids 61, 339–345.CrossRefGoogle ScholarPubMed
Zoli, G, Carè, M, Parazza, M, Spanò, C, Biagi, PL, Bernardi, M & Gasbarrini, G (1997) A randomised controlled study comparing elemental diet and steroid treatment in Crohn's disease. Alimentary Pharmacology and Therapeutics 11, 735–740.CrossRefGoogle ScholarPubMed